Changes in magnesium and potassium homeostasis after conversion from a calcineurin inhibitor regimen to an mTOR inhibitorbased regimen

Transplantation Proceedings

Volumn 42, Issue 8, 2010, Pages 3047-3049

  Sanchez Fructuoso A I ^a,b   Santn Cantero, J M ^a,b   Perez Flores I ^a,b   Valero San Cecilio, R ^a,b   Calvo Romero, N ^a,b   Vilalta Casas, R ^a,b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE; CREATININE; CYCLOSPORIN; GLUCOSE; MAGNESIUM; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; POTASSIUM; SODIUM; TACROLIMUS; UREA;

ADULT; ANION GAP; BICARBONATE BLOOD LEVEL; CARDIOVASCULAR DISEASE; CHLORIDE BLOOD LEVEL; CHLORIDE URINE LEVEL; CHRONIC ALLOGRAFT NEPHROPATHY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DRUG INDICATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; GRAFT RECIPIENT; HUMAN; KIDNEY ALLOGRAFT; MAGNESIUM BLOOD LEVEL; MAGNESIUM URINE LEVEL; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NEPHROTOXICITY; PLASMA OSMOLARITY; POTASSIUM BLOOD LEVEL; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; VASCULAR DISEASE;

EID: 77958581930     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.07.081     Document Type: Article

References (15)

1. P. Merville Combating chronic renal allograft dysfunction: optimal immunosuppressive regimens Drugs 65 2005 615
2. B.J. Nankivell, R.J. Borrows, and C.L. Fung The natural history of chronic allograft nephropathy N Engl J Med 349 2003 2326
3. A.J. Olyaei, A.M. de Mattos, and W.M. Bennett Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies Curr Opin Crit Care 7 2001 384
4. A.O. Ojo, P.J. Held, and F.K. Port Chronic renal failure after transplantation of a nonrenal organ N Engl J Med 349 2003 931
5. A.C. Shirali, and M.J. Bia Management of cardiovascular disease in renal transplant recipients Clin J Am Soc Nephrol 3 2008 491
6. M. Guba, C. Graeb, K.W. Jauch, and E.K. Geissler Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation Transplantation 77 2004 1777
7. A.V. Mulay, S. Cockfield, and R. Stryker Conversion from calcineurin inhibitors to sirolimus for chronic renal allograft dysfunction: a systematic review of the evidence Transplantation 82 2006 1153
8. P. Heering, K. Ivens, S. Aker, and B. Grabensee Distal tubular acidosis induced by FK506 Clin Transplant 12 1998 465
9. P. Heering, and B. Grabensee Influence of cyclosporin A on renal tubular function after kidney transplantation Nephron 59 1991 66
10. 2+ ions Nephrol Dial Transplant 18 2003 2262
11. C.T. Chang, C.C. Hung, and Y.C. Tian Cyclosporin reduces paracellin-1 expression and magnesium transport in thick ascending limb cells Nephrol Dial Transplant 22 2007 1033
12. M. Hauben Cyclosporine neurotoxicity Pharmacotherapy 16 1996 576
13. R. Holzmacher, C. Kendziorski, and R. Michael Hofman Low serum magnesium is associated with decreased graft survival in patients with chronic cyclosporin nephrotoxicity Nephrol Dial Transplant 20 2005 1456
14. K. Miura, T. Nakatani, and T. Asai Role of hypomagnesemia in chronic cyclosporine nephropathy Transplantation 73 2002 340
15. F. Sabbagh, Z. El Tawil, and F. Lecerf Impact of cyclosporine A on magnesium homeostasis: clinical observation in lung transplant recipients and experimental study in mice Transplantation 86 2008 436